Literature DB >> 19460752

A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.

Man Lung Yeung1, Laurent Houzet, Venkat S R K Yedavalli, Kuan-Teh Jeang.   

Abstract

Short interfering RNAs (siRNAs) have been used to inhibit HIV-1 replication. The durable inhibition of HIV-1 replication by RNA interference has been impeded, however, by a high mutation rate when viral sequences are targeted and by cytotoxicity when cellular genes are knocked down. To identify cellular proteins that contribute to HIV-1 replication that can be chronically silenced without significant cytotoxicity, we employed a shRNA library that targets 54,509 human transcripts. We used this library to select a comprehensive population of Jurkat T-cell clones, each expressing a single discrete shRNA. The Jurkat clones were then infected with HIV-1. Clones that survived viral infection represent moieties silenced for a human mRNA needed for virus replication, but whose chronic knockdown did not cause cytotoxicity. Overall, 252 individual Jurkat mRNAs were identified. Twenty-two of these mRNAs were secondarily verified for their contributions to HIV-1 replication. Five mRNAs, NRF1, STXBP2, NCOA3, PRDM2, and EXOSC5, were studied for their effect on steps of the HIV-1 life cycle. We discuss the similarities and differences between our shRNA findings for HIV-1 using a spreading infection assay in human Jurkat T-cells and results from other investigators who used siRNA-based screenings in HeLa or 293T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460752      PMCID: PMC2740572          DOI: 10.1074/jbc.M109.010033

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Host factors exploited by retroviruses.

Authors:  Stephen P Goff
Journal:  Nat Rev Microbiol       Date:  2007-02-26       Impact factor: 60.633

Review 2.  RISCy business: MicroRNAs, pathogenesis, and viruses.

Authors:  Ben Berkhout; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2007-07-12       Impact factor: 5.157

Review 3.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

4.  Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1.

Authors:  Jeffrey H Ringrose; Rienk E Jeeninga; Ben Berkhout; Dave Speijer
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 5.  PTEN: a new guardian of the genome.

Authors:  Y Yin; W H Shen
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

6.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

7.  Identification of host proteins required for HIV infection through a functional genomic screen.

Authors:  Abraham L Brass; Derek M Dykxhoorn; Yair Benita; Nan Yan; Alan Engelman; Ramnik J Xavier; Judy Lieberman; Stephen J Elledge
Journal:  Science       Date:  2008-01-10       Impact factor: 47.728

Review 8.  Host factors influencing susceptibility to HIV infection and AIDS progression.

Authors:  Juan Lama; Vicente Planelles
Journal:  Retrovirology       Date:  2007-07-25       Impact factor: 4.602

Review 9.  RNAi therapy for HIV infection: principles and practicalities.

Authors:  Yamina Bennasser; Man Lung Yeung; Kuan-Teh Jeang
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

10.  Optimal design and validation of antiviral siRNA for targeting HIV-1.

Authors:  Yuki Naito; Kyoko Nohtomi; Toshinari Onogi; Rie Uenishi; Kumiko Ui-Tei; Kaoru Saigo; Yutaka Takebe
Journal:  Retrovirology       Date:  2007-11-08       Impact factor: 4.602

View more
  150 in total

1.  An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.

Authors:  Casey W Shuptrine; Reham Ajina; Elana J Fertig; Sandra A Jablonski; H Kim Lyerly; Zachary C Hartman; Louis M Weiner
Journal:  Cancer Immunol Immunother       Date:  2017-08-02       Impact factor: 6.968

2.  A novel method to convert a DNA fragment inserted into a plasmid to an inverted repeat structure.

Authors:  Kazuya Tomimoto; Kosuke Fujita; Jun Ishibashi; Shigeo Imanishi; Minoru Yamakawa; Hiromitsu Tanaka
Journal:  Mol Biotechnol       Date:  2012-01       Impact factor: 2.695

3.  Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Authors:  Natallia Dziuba; Monique R Ferguson; William A O'Brien; Anthony Sanchez; Andrew J Prussia; Natalie J McDonald; Brian M Friedrich; Guangyu Li; Michael W Shaw; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; James L Murray
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

4.  Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

Authors:  Souad Naji; Géza Ambrus; Peter Cimermančič; Jason R Reyes; Jeffrey R Johnson; Rebecca Filbrandt; Michael D Huber; Paul Vesely; Nevan J Krogan; John R Yates; Andrew C Saphire; Larry Gerace
Journal:  Mol Cell Proteomics       Date:  2011-12-15       Impact factor: 5.911

Review 5.  Host genes important to HIV replication and evolution.

Authors:  Amalio Telenti; Welkin E Johnson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 6.  A primer on using pooled shRNA libraries for functional genomic screens.

Authors:  Guang Hu; Ji Luo
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-02       Impact factor: 3.848

Review 7.  Selection of RNAi-based inhibitors for anti-HIV gene therapy.

Authors:  Stefanie A Knoepfel; Mireille Centlivre; Ying Poi Liu; Fatima Boutimah; Ben Berkhout
Journal:  World J Virol       Date:  2012-06-12

8.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

9.  Comparative analysis of RNAi screening technologies at genome-scale reveals an inherent processing inefficiency of the plasmid-based shRNA hairpin.

Authors:  Bhavneet Bhinder; David Shum; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2014-02       Impact factor: 1.339

Review 10.  HIV-1 assembly in macrophages.

Authors:  Philippe Benaroch; Elisabeth Billard; Raphaël Gaudin; Michael Schindler; Mabel Jouve
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.